NDC Active Ingredient Alirocumab

Active Ingredient Information

What is the usage for Alirocumab?

Alirocumab is used by people who have blockage in the heart blood vessels to reduce the risk of heart attack, stroke, and certain types of chest pain that require treatment in a hospital. It is also used by people who have an inherited condition that causes high levels of LDL. Treatment with alirocumab, a proper diet, and cholesterol-lowering drugs can help lower "bad" cholesterol (LDL) in the blood. Alirocumab belongs to a class of drugs known as monoclonal antibodies. It works by improving how well your body gets rid of LDL cholesterol. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

How many products in the NDC database contain Alirocumab?

The NDC database has 8 products with the active ingredient Alirocumab. The following table lists all the products that have this active ingredient.

NDC Products with Alirocumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0024-5901Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5902Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5903Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5904Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
61755-020Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousRegeneron Pharmaceuticals, Inc.ACTIVE
61755-021Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousRegeneron Pharmaceuticals, Inc.ACTIVE
72733-5901Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousSanofi Us CorporationACTIVE
72733-5902Proprietary Name: Praluent AlirocumabInjection, SolutionSubcutaneousSanofi Us CorporationACTIVE
<